Advertisement
Screener

Zosano Pharma Corp Net Cash Provided by (Used in) Financing Activities, Continuing Operations

Zosano Pharma Corp Net Cash Provided by (Used in) Financing Activities, Continuing Operations

Zosano Pharma Corp reported Net Cash Provided by (Used in) Financing Activities, Continuing Operations of $45.82 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-25.

Discontinued › Cash Flow › Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations · last filed 2019-03-25

  • Zosano Pharma Corp net cash provided by (used in) financing activities, continuing operations for the quarter ending 2018-03-31 was -$1.53M, a 105.20% decline year-over-year.
  • Zosano Pharma Corp net cash provided by (used in) financing activities, continuing operations for the quarter ending 2017-12-31 was -$1.50M.
  • Zosano Pharma Corp net cash provided by (used in) financing activities, continuing operations for the quarter ending 2017-09-30 was -$1.46M, a 127.74% decline year-over-year.
  • Zosano Pharma Corp net cash provided by (used in) financing activities, continuing operations for the quarter ending 2017-06-30 was -$1.44M, a 28820.00% decline year-over-year.
  • Zosano Pharma Corp net cash provided by (used in) financing activities, continuing operations for fiscal 2018 was $45.82M, a 83.33% increase from fiscal 2017.
  • Zosano Pharma Corp net cash provided by (used in) financing activities, continuing operations for fiscal 2017 was $25.00M, a 562.82% increase from fiscal 2016.
  • Zosano Pharma Corp net cash provided by (used in) financing activities, continuing operations for fiscal 2016 was $3.77M, a 93.77% decline from fiscal 2015.
  • Zosano Pharma Corp net cash provided by (used in) financing activities, continuing operations for fiscal 2015 was $60.53M, a 723.69% increase from fiscal 2014.
Period endNet Cash Provided by (Used in) Financing Activities, Continuing Operations 3 monthNet Cash Provided by (Used in) Financing Activities, Continuing Operations 6 monthNet Cash Provided by (Used in) Financing Activities, Continuing Operations 9 monthNet Cash Provided by (Used in) Financing Activities, Continuing Operations 12 month
2018-12-31$45.82M
10-K · filed 2019-03-25
2018-03-31-$1.53M
10-Q · filed 2018-05-15
-$3.02M
derived: sum of 2 quarters · filed 2019-03-25
-$4.49M
derived: sum of 3 quarters · filed 2019-03-25
-$5.92M
derived: sum of 4 quarters · filed 2019-03-25
2017-12-31-$1.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25
-$2.96M
derived: sum of 2 quarters · filed 2019-03-25
-$4.40M
derived: sum of 3 quarters · filed 2019-03-25
$25.00M
10-K · filed 2019-03-25
2017-09-30-$1.46M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
-$2.90M
derived: sum of 2 quarters · filed 2017-11-09
$26.49M
10-Q · filed 2017-11-09
$24.98M
derived: sum of 4 quarters · filed 2018-05-15
2017-06-30-$1.44M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10
$27.95M
10-Q · filed 2017-08-10
$26.44M
derived: sum of 3 quarters · filed 2018-05-15
$31.72M
derived: sum of 4 quarters · filed 2018-05-15
2017-03-31$29.39M
10-Q · filed 2018-05-15
$27.88M
derived: sum of 2 quarters · filed 2018-05-15
$33.16M
derived: sum of 3 quarters · filed 2018-05-15
$33.16M
derived: sum of 4 quarters · filed 2018-05-15
2016-12-31-$1.51M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12
$3.77M
derived: sum of 2 quarters · filed 2018-03-12
$3.77M
derived: sum of 3 quarters · filed 2018-03-12
$3.77M
10-K · filed 2018-03-12
2016-09-30$5.28M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$5.28M
derived: sum of 2 quarters · filed 2017-11-09
$5.28M
10-Q · filed 2017-11-09
$5.28M
derived: sum of 4 quarters · filed 2017-11-09
2016-06-30$5.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10
$6.00K
10-Q · filed 2017-08-10
$6.00K
derived: sum of 3 quarters · filed 2017-08-10
$2.00K
derived: sum of 4 quarters · filed 2017-08-10
2016-03-31$1.00K
10-Q · filed 2017-05-09
$1.00K
derived: sum of 2 quarters · filed 2017-05-09
-$3.00K
derived: sum of 3 quarters · filed 2017-05-09
$337.00K
derived: sum of 4 quarters · filed 2017-05-09
2015-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01
-$4.00K
derived: sum of 2 quarters · filed 2017-03-01
$336.00K
derived: sum of 3 quarters · filed 2017-03-01
$60.53M
10-K · filed 2017-03-01
2015-09-30-$4.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
$336.00K
derived: sum of 2 quarters · filed 2016-11-09
$60.53M
10-Q · filed 2016-11-09
$61.46M
derived: sum of 4 quarters · filed 2016-11-09
2015-06-30$340.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10
$60.54M
10-Q · filed 2016-08-10
$61.46M
derived: sum of 3 quarters · filed 2016-08-10
$61.47M
derived: sum of 4 quarters · filed 2016-08-10
2015-03-31$60.20M
10-Q · filed 2016-05-12
$61.12M
derived: sum of 2 quarters · filed 2016-05-12
$61.13M
derived: sum of 3 quarters · filed 2016-05-12
$65.05M
derived: sum of 4 quarters · filed 2016-05-12
2014-12-31$927.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29
$929.00K
derived: sum of 2 quarters · filed 2016-03-29
$4.85M
derived: sum of 3 quarters · filed 2016-03-29
$7.35M
10-K · filed 2016-03-29
2014-09-30$2.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10
$3.92M
derived: sum of 2 quarters · filed 2015-11-10
$6.42M
10-Q · filed 2015-11-10
2014-06-30$3.92M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13
$6.42M
10-Q · filed 2015-08-13
2014-03-31$2.50M
10-Q · filed 2015-05-12